SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-019019
Filing Date
2024-04-29
Accepted
2024-04-29 16:30:06
Documents
19
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A abcl-20240429.htm   iXBRL DEF 14A 712103
6 abcl-20240429_g1.jpg GRAPHIC 21340
7 abcl-20240429_g2.jpg GRAPHIC 57944
8 abcl-20240429_g3.jpg GRAPHIC 75849
9 abcl-20240429_g4.jpg GRAPHIC 63359
10 abcl-20240429_g5.jpg GRAPHIC 60472
  Complete submission text file 0001628280-24-019019.txt   2017785

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20240429.xsd EX-101.SCH 2299
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abcl-20240429_def.xml EX-101.DEF 2301
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20240429_lab.xml EX-101.LAB 2819
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20240429_pre.xml EX-101.PRE 1382
22 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20240429_htm.xml XML 130687
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39781 | Film No.: 24891419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)